PainChek logo

PCK - PainChek Share Price

A$0.08 0.0  2.6%

Last Trade - 26/02/21

Sector
Technology
Size
Micro Cap
Market Cap £46.5m
Enterprise Value £43.1m
Revenue £167k
Position in Universe 900th / 1832
Bullish
Bearish
Unlock PCK Revenue
Momentum
Relative Strength (%)
1m +14.6%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -59.0%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Jun 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.001 0.001 0.031 0.051 0.22 0.30 3.30 5.60 +252%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 30 June 2020, PainChek Ltdrevenues increased 38% to A$297K. Net loss increased fromA$3.3M to A$12.4M. Revenues reflect Revenue from contractswith customers increase of 84% to A$248K. Higher net lossreflects Share based payment expenses increase from A$113Kto A$8.9M (expense), Selling/General/Admin Expense increaseof 73% to A$1.3M (expense), Research and developmentexpenses increase of 20% to A$2.3M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

PCK Revenue Unlock PCK Revenue

Net Income

PCK Net Income Unlock PCK Revenue

Normalised EPS

PCK Normalised EPS Unlock PCK Revenue

PE Ratio Range

PCK PE Ratio Range Unlock PCK Revenue

Dividend Yield Range

PCK Dividend Yield Range Unlock PCK Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
PCK EPS Forecasts Unlock PCK Revenue
Profile Summary

PainChek Ltd, formerly EPAT Technologies Limited, is an Australia-based company, which is principally engaged in developing mobile medical application that provide pain assessment for individuals that are unable to communicate with their carers. The Company's mobile medical application, Painchek, uses the facial recognition software to facilitate and improve pain assessment in patients. The Company intends to develop, and has rolled out its mobile medical applications in two phases, which include patients with dementia and lost the ability to communicate with their carers and for young children not yet speaking. The data captured through the mobile medical applications is combined with non-facial pain cues, including vocalizations, movements and behaviors to automatically calculate a pain severity score.

Directors
Last Annual June 30th, 2020
Last Interim June 30th, 2020
Incorporated August 27, 2010
Public Since May 1, 2012
No. of Shareholders: 5,106
No. of Employees: n/a
Sector Technology
Industry Software & IT Services
Index S&P/ASX All Ordinaries ,
Exchange Australian Stock Exchange - SEATS
Shares in Issue 1,035,522,400
Free Float (0.0%)
Eligible for
ISAs
SIPPs
PCK Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for PCK
Upcoming Events for PCK
Frequently Asked Questions for PainChek
What is the PainChek share price?

As of 26/02/21, shares in PainChek are trading at A$0.08, giving the company a market capitalisation of £46.5m. This share price information is delayed by 15 minutes.

How has the PainChek share price performed this year?

Shares in PainChek are currently trading at A$0.08 and the price has moved by -30.43% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the PainChek price has moved by -32.47% over the past year.

What are the analyst and broker recommendations for PainChek?

There are no analysts currently covering PainChek.

When will PainChek next release its financial results?

PainChek is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the PainChek dividend yield?

PainChek does not currently pay a dividend.

Does PainChek pay a dividend?

PainChek does not currently pay a dividend.

When does PainChek next pay dividends?

PainChek does not currently pay a dividend.

How do I buy PainChek shares?

To buy shares in PainChek you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of PainChek?

Shares in PainChek are currently trading at A$0.08, giving the company a market capitalisation of £46.5m.

Where are PainChek shares listed? Where are PainChek shares listed?

Here are the trading details for PainChek:

Country of listing: Australia
Exchange: ASX
Ticker Symbol: PCK
What kind of share is PainChek?

Based on an overall assessment of its quality, value and momentum, PainChek is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a PainChek share price forecast 2021?

Shares in PainChek are currently priced at A$0.08. At that level they are trading at 0.338% discount to the analyst consensus target price of 0.00.

Analysts covering PainChek currently have a consensus Earnings Per Share (EPS) forecast of -0.003 for the next financial year.

How can I tell whether the PainChek share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like PainChek. Over the past six months, the relative strength of its shares against the market has been -28.01%. At the current price of A$0.08, shares in PainChek are trading at -20.87% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the PainChek PE Ratio?

We were not able to find PE ratio data for PainChek.

Who are the key directors of PainChek?

PainChek's management team is headed by:

Adam Davey - NED
Stephen Kelly - CFO
Scott Robertson - CTO
Who are the major shareholders of PainChek?

Here are the top five shareholders of PainChek based on the size of their shareholding:

Peters Investments Pty. Ltd. Corporation
Percentage owned: 10.03% (113.0m shares)
J & E Consulting Pty. Ltd. Corporation
Percentage owned: 3.28% (37.0m shares)
Atee (Mustafa Abdul Wahed) Individual Investor
Percentage owned: 3.28% (37.0m shares)
Hoti (Kreshnik) Individual Investor
Percentage owned: 3.28% (37.0m shares)
Healy (Robert Anthony) Individual Investor
Percentage owned: 1.94% (21.9m shares)
Similar to PCK
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.